跳至主要内容
临床试验/IRCT20200402046915N1
IRCT20200402046915N1招募中3 期

Assessment of the therapeutic effect of intravesical Gemcitabine compared with intravesical BCG in non-muscle invasive urothelial carcinoma of the bladder, subgroups of intermediate-risk

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All the patients with bladder cancer who are not candidates for chemotherapy or bladder removal surgery.
  • Patients with no history of TURT surgery.
  • Patients have no history of intravesical injections.
  • Patients respond to the initial pathology under the moderate risk group with no muscle involvement.

排除标准

  • Patients with ruptured bladder during TURT surgery.
  • Patients with immunodeficiency.
  • Patients who are pregnant.
  • Patients who are unable to perform TURT due to urethral stricture or urethral obstruction.
  • Patients with a history of intravesical injections.

研究者

相似试验

Assessment of the therapeutic effect of intravesical... | 临床试验